Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


NACDS names marketing head

This article was originally published in The Tan Sheet

Executive Summary

The National Association of Chain Drug Stores taps Christopher P. Krese senior VP marketing, communications and media relations, effective April 19, the organization says. Krese comes to NACDS with 14 years of experience in trade associations, congressional offices and public affairs; previously, he served as senior VP of industry affairs for the American Frozen Food Institute. "Chris is the best in the business when it comes to industry and association messaging, branding and positioning," NACDS President and CEO Steven C. Anderson said. Krese will report directly to Anderson. The appointment follows NACDS' April 4 announcement of a communications department overhaul (1"The Tan Sheet" April 9, 2007, p. 16)...

You may also be interested in...

People In Brief

Cargill hires support for Omega-3 foray: Cargill's new omega-3 ingredient "promises to be an innovative alternative to existing omega-3 products in the area of flavor," the company announces in a March 29 release. To support the product's launch and Cargill's entry into the fish oil market, the firm hired David Lewis as omega-3 product manager. Lewis has been business unit director for Lipid Nutrition in North America, responsible for its nutritional oil business. He brings "solid, specialty ingredient sales and marketing skills to our business," Cargill said. Lewis will report to David Henstrom, general manager, Europe, Middle East and Africa...

Roche/Genentech Keeps Commitment To External Cancer Innovation

Roche/Genentech oncology partnering maintained a robust dealmaking pace through the pandemic, keeping the percentage of partnered R&D programs at about 50% of the cancer drug pipeline.

US FDA Eases Changes For Certain Sterile Injectable Container Closure Materials

To mitigate pandemic disruption of component supply chains, the US FDA said it will downgrade some post-approval change categories for sterile drug container closure systems. The downgrade will cover drugs in shortage and those used to treat COVID-19.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts